Brain Stimulation for Primary Progressive Aphasia
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to test a new brain stimulation technique, Personalized Closed-Loop Brain Stimulation, to assist individuals with Primary Progressive Aphasia (PPA), a condition affecting language skills. The study employs a personalized approach, adjusting the treatment based on real-time brain activity to enhance memory and learning. Participants will also engage in cognitive exercises. Suitable candidates have a specific type of PPA and can participate in language and memory tests. As an unphased trial, this study provides a unique opportunity to contribute to cutting-edge research that could lead to new treatments for PPA.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study team or your doctor.
What prior data suggests that this personalized closed-loop brain stimulation is safe for individuals with Primary Progressive Aphasia?
Research has shown that noninvasive brain stimulation is generally well-tolerated by people with Primary Progressive Aphasia (PPA). This treatment uses electrical currents to stimulate the brain and typically does not cause serious side effects. Most individuals experience only mild issues, such as tingling or skin irritation at the electrode sites.
Reviews of this treatment indicate that most participants experience no side effects or only minor ones, suggesting its safety for many people. However, as with any medical treatment, experiences can vary. Participants should discuss any concerns with the trial organizers and their healthcare providers.12345Why are researchers excited about this trial?
Unlike the standard therapies for Primary Progressive Aphasia, which often focus on speech therapy and medications to manage symptoms, personalized closed-loop brain stimulation offers a novel approach by directly stimulating specific brain areas. This treatment delivers targeted electrical stimulation (tES) in combination with cognitive exercises, potentially enhancing brain plasticity and improving language function more effectively. Researchers are excited about this method because it tailors the stimulation to the individual's brain activity, providing a customized and dynamic intervention that could lead to more significant improvements in speech and cognitive abilities.
What evidence suggests that this personalized closed-loop brain stimulation is effective for Primary Progressive Aphasia?
Studies have shown that personalized brain stimulation can help treat Primary Progressive Aphasia (PPA). This method uses AI to tailor electrical stimulation to each person's brain needs, achieving better results than one-size-fits-all approaches. Research indicates that targeted brain stimulation can enhance language skills and brain function in people with PPA. In this trial, participants will receive personalized, closed-loop brain stimulation combined with cognitive interventions. A review found that noninvasive brain stimulation, such as this, shows promise when paired with language therapy. Early findings suggest that this personalized approach aids learning and memory, offering hope for those with PPA.12367
Who Is on the Research Team?
Kyrana Tsapkini, PhD
Principal Investigator
Johns Hopkins University
Are You a Good Fit for This Trial?
This trial is for people aged 45-85 who have been diagnosed with a specific type of language disorder called primary progressive aphasia (PPA) linked to Alzheimer's disease. Participants must be right-handed, speak English well, and have at least a high school education.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive personalized, closed-loop active tES for 3 weeks, with concurrent cognitive training exercises
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Personalized Closed-Loop Brain Stimulation
Trial Overview
The study tests if personalized brain stimulation using real-time EEG-guided electrical currents (tES), combined with computer-based cognitive training, can help improve learning and memory in people with PPA. The treatment is tailored to each person and lasts 6-8 weeks.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Participants will receive personalized, closed-loop active tES for 3 weeks. Active tES will be administered for 20 minutes. Cognitive training exercises will be administered concurrently with the tES and will take approximately 30 minutes to complete.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Johns Hopkins University
Lead Sponsor
Mackler-Goding Foundation
Collaborator
Citations
Personalized Closed-Loop Brain Stimulation for Patients With ...
This research study investigates the feasibility and efficacy of a personalized, closed-loop electroencephalogram-transcranial electrical stimulation ...
Noninvasive Brain Stimulation in Primary Progressive Aphasia ...
Survival following diagnosis is about 5 years for nfvPPA and 9 years for svPPA (Coyle-Gilchrist et al., 2016), whereas survival data in lvPPA ...
Brain Stimulation for Primary Progressive Aphasia
This research study investigates the feasibility and efficacy of a personalized, closed-loop electroencephalogram-transcranial electrical stimulation ...
Enhancing Language Function in Primary Progressive ...
This study's goal is to use non-invasive brain stimulation (NBS) techniques to treat language impairment associated with Primary Progressive Aphasia (PPA).
Effectiveness of language training and non-invasive brain ...
The aim of this systematic review and meta-analysis was to evaluate the effectiveness of language training focused on oral and written naming in Primary ...
Transcranial Magnetic Stimulation in Primary Progressive ...
Recent studies have shown how repetitive TMS improved language characteristics in Alzheimer's disease, and there are initial data in patients with PPA. This ...
Safety and Efficacy of Different Therapeutic Interventions ...
Noninvasive brain stimulation in primary progressive aphasia with and without concomitant speech and language therapy: Systematic review and meta-analysis ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.